N

Noile-Immune Biotech Inc
TSE:4893

Watchlist Manager
Noile-Immune Biotech Inc
TSE:4893
Watchlist
Price: 160 JPY -1.23% Market Closed
Market Cap: 6.9B JPY
Have any thoughts about
Noile-Immune Biotech Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
Noile-Immune Biotech Inc

Wall Street analysts forecast Noile-Immune Biotech Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Noile-Immune Biotech Inc is 448.8 JPY with a low forecast of 444.4 JPY and a high forecast of 462 JPY.

Lowest
Price Target
444.4 JPY
178% Upside
Average
Price Target
448.8 JPY
181% Upside
Highest
Price Target
462 JPY
189% Upside
Noile-Immune Biotech Inc Competitors:
Price Targets
301207
Hualan Biological Bacterin Inc
63% Upside
1801
Innovent Biologics Inc
65% Upside
QNCX
Quince Therapeutics Inc
416% Upside
ITOS
Iteos Therapeutics Inc
244% Upside
2616
CStone Pharmaceuticals
11% Upside
SPRO
Spero Therapeutics Inc
434% Upside
302440
SK Bioscience Co Ltd
2% Downside

Revenue
Forecast

Revenue Estimate
Noile-Immune Biotech Inc

For the last 2 years the compound annual growth rate for Noile-Immune Biotech Inc's revenue is 77%. The projected CAGR for the next 3 years is 1%.

77%
Past Growth
1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Noile-Immune Biotech Inc

Operating Income forecast
is not available for
Noile-Immune Biotech Inc

Net Income
Forecast

Net Income Estimate
Noile-Immune Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Noile-Immune Biotech Inc's stock price target?
Price Target
448.8 JPY

According to Wall Street analysts, the average 1-year price target for Noile-Immune Biotech Inc is 448.8 JPY with a low forecast of 444.4 JPY and a high forecast of 462 JPY.

What is Noile-Immune Biotech Inc's Revenue forecast?
Projected CAGR
1%

For the last 2 years the compound annual growth rate for Noile-Immune Biotech Inc's revenue is 77%. The projected CAGR for the next 3 years is 1%.

Back to Top